Home > Insider Trading > Filing (0001549084-22-000078)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1549084	Ekso Bionics Holdings Inc.	EKSO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1201619	Steven Sherman	C/O Ekso Bionics Holdings, Inc. 101 Glacier Point, Suite A San Rafael CA 94901	Executive Chair	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-12-04	31,198	$0.00	739,240	No	4	M	Direct
Common Stock	Disposition	2022-12-04	10,576	$1.28	728,664	No	4	S	Direct
Common Stock	Acquisiton	2022-12-04	242,679	$0.00	971,343	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2022-12-04	31,198	$0.00	31,198	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Footnotes

Represents shares sold by the Reporting Person on December 7, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the remaining securities under a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022.
The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $1.2700 to $1.3310, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.
The grant of restricted stock units ("RSUs") was approved by the Issuer's Board of Directors on December 4, 2022 in accordance with the terms of the Issuer's Amended and Restated 2014 Equity Incentive Plan. Each RSU represents the economic equivalent of one share of the Issuer's common stock and shall be settled in shares of the Issuer's common stock upon vesting. The RSUs shall fully vest on January 31, 2023.
Includes 242,579 unvested RSUs.
The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date").
On December 4, 2022, the Issuer's Board of Directors approved an amendment to the vesting schedule of the RSUs such that the RSUs fully vested and were delivered to the Reporting Person upon settlement.